Luminous
A Catholic Woman and Her Thoughts on Life, the Universe, and Everything
Saturday, February 18, 2006
Even My Kid Has More Sense Than This...
My teenaged son has seen the commercials for this product, and has been mystified. In the United States, pharmaceutical companies are required by law to reveal any side effects if they actually discuss what the medication is used for when they push their products on TV - so during the deliberately sexy presentation, with the half-dressed nubile young female discussing the wonders of the birth-control patch, we suddely hear the rapidly speaking announcer jabber that there is "some risk" of heart attack, stroke, and blood clots, especially if the woman smokes. My son, brilliant child that he is, watches this, then turns to me and asks, "If you loved someone, why would you want her to use something like that?" From the mouth of babes....
Clot Risk for Birth-Control Patch Is Found to Be Double That of Pill
By THE ASSOCIATED PRESS
WASHINGTON, Feb. 17 (AP) — A new study shows that women using the Ortho Evra birth-control patch have double the risk of developing blood clots compared with those who take the birth-control pill, the Food and Drug Administration said Friday.
But the agency called the results preliminary and said they did not require immediate action other than advising women to discuss the risk with their doctors.
The finding comes from one of two studies comparing the patch and the pill, said Ortho Women's Health and Urology, maker of the once-a-week patch. The company, based in Raritan, N.J., is owned by Johnson & Johnson.
Last year an investigation by The Associated Press, citing federal death and injury reports, found higher rates of blood clots in women using the patch.
The first study found no increased risk of clots. But the interim results from the second study suggested a twofold increase in the risk of venous thromboembolic events, or clots in the legs and lungs, in women using the patch, Ortho said.
At a briefing on Friday, Dr. Daniel Shames, director of the division of reproductive and urological drug products at the F.D.A., said the risk of a nonfatal blood clot was about one per year in 10,000 women not using a contraceptive. For those using a hormonal contraceptive like the patch or pill, the risk rises to 3 to 5 per 10,000, Dr. Shames said.
He noted that in preapproval testing of the patch on about 3,000 women, there were two reports of blood clots, but that one involved a woman who had had surgery.
The continuing studies are also looking at the risk of heart attacks and strokes among users of the two types of contraception. Currently, there is no difference, but the numbers are small, and it will take 18 more months to see if a difference occurs, Dr. Shames said.
The company said the risk of clots remained rare and added that clots were a potential risk of all hormonal contraceptives.
Release of the interim results comes four months after the drug agency warned women that the increased levels of hormones released by the patch put them at higher risk of blood clots and other serious side effects. Ortho said it shared the results of the latest studies with the agency.
Additions to the patch label in November warned women that they would be exposed to about 60 percent more estrogen than those who used birth-control pills.
Since the patch went on sale in 2002, more than four million women have used it.
The investigation by The Associated Press found that patch users died and suffered blood clots at a rate three times as high as that for women taking the pill. About a dozen women died in 2004 from blood clots believed to be linked to the patch, The Associated Press reported.
Health officials warn that women who smoke should not use the patch, because smoking increases the risk of stroke and heart attack.
About the Pill - What the Drug Companies Don't Want You to Know
http://ccli.org/nfp/contraception/pill.php
Pope John Paul II's "Theology of the Body
An Overview by Christopher West
http://www.theologyofthebody.net/articles/tob_education.htm
CCC on Marriage, Sexuality, and Artificial Contraception
http://www.scborromeo.org/ccc/p3s2c2a6.htm
Clot Risk for Birth-Control Patch Is Found to Be Double That of Pill
By THE ASSOCIATED PRESS
WASHINGTON, Feb. 17 (AP) — A new study shows that women using the Ortho Evra birth-control patch have double the risk of developing blood clots compared with those who take the birth-control pill, the Food and Drug Administration said Friday.
But the agency called the results preliminary and said they did not require immediate action other than advising women to discuss the risk with their doctors.
The finding comes from one of two studies comparing the patch and the pill, said Ortho Women's Health and Urology, maker of the once-a-week patch. The company, based in Raritan, N.J., is owned by Johnson & Johnson.
Last year an investigation by The Associated Press, citing federal death and injury reports, found higher rates of blood clots in women using the patch.
The first study found no increased risk of clots. But the interim results from the second study suggested a twofold increase in the risk of venous thromboembolic events, or clots in the legs and lungs, in women using the patch, Ortho said.
At a briefing on Friday, Dr. Daniel Shames, director of the division of reproductive and urological drug products at the F.D.A., said the risk of a nonfatal blood clot was about one per year in 10,000 women not using a contraceptive. For those using a hormonal contraceptive like the patch or pill, the risk rises to 3 to 5 per 10,000, Dr. Shames said.
He noted that in preapproval testing of the patch on about 3,000 women, there were two reports of blood clots, but that one involved a woman who had had surgery.
The continuing studies are also looking at the risk of heart attacks and strokes among users of the two types of contraception. Currently, there is no difference, but the numbers are small, and it will take 18 more months to see if a difference occurs, Dr. Shames said.
The company said the risk of clots remained rare and added that clots were a potential risk of all hormonal contraceptives.
Release of the interim results comes four months after the drug agency warned women that the increased levels of hormones released by the patch put them at higher risk of blood clots and other serious side effects. Ortho said it shared the results of the latest studies with the agency.
Additions to the patch label in November warned women that they would be exposed to about 60 percent more estrogen than those who used birth-control pills.
Since the patch went on sale in 2002, more than four million women have used it.
The investigation by The Associated Press found that patch users died and suffered blood clots at a rate three times as high as that for women taking the pill. About a dozen women died in 2004 from blood clots believed to be linked to the patch, The Associated Press reported.
Health officials warn that women who smoke should not use the patch, because smoking increases the risk of stroke and heart attack.
About the Pill - What the Drug Companies Don't Want You to Know
http://ccli.org/nfp/contraception/pill.php
Pope John Paul II's "Theology of the Body
An Overview by Christopher West
http://www.theologyofthebody.net/articles/tob_education.htm
CCC on Marriage, Sexuality, and Artificial Contraception
http://www.scborromeo.org/ccc/p3s2c2a6.htm
1 Comments:
Patti said...
More estrogen from the patch can lead to some women developing breast cancer also.
Archive
January 2006February 2006
March 2006
April 2006
May 2006
July 2006
August 2006
October 2006
November 2006
December 2006
February 2007
March 2007
April 2007
May 2007
July 2007
September 2007
November 2007
December 2007
January 2008
February 2008
April 2008
May 2008
June 2008
September 2008
October 2008
November 2008
February 2009
March 2009
April 2009
May 2009
July 2009
August 2009
September 2009
October 2009
November 2009
January 2010
February 2010
April 2010
August 2010
September 2010
November 2010
December 2010
January 2011
June 2012
February 2015
Links
- by Thomas à Kempis
Blogs
